This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/10/2023
Operator
Conference Operator
Ladies and gentlemen, thank you for standing by. Welcome to the October Therapeutics.
Dr. Steve Fruchtman
President & CEO, Onconova Therapeutics
Sarah, excuse me. You're coming in and out. I don't know if other people hear you coming in and out.
Operator
Conference Operator
Thank you. Let me restart. Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics second quarter 2023 financial results and business update conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a question and answer session. To ask a question at that time, please press star followed by one on your touchtone phone. If anyone has difficulty hearing the conference, please press star zero for operator assistance. As a reminder, this call is being recorded today, August 10, 2023. At this time, I would like to turn the call over to Bruce Mackel of LifeSci Advisors. Go ahead.
You're reading a preview of the ONTX Q2 2023 earnings call.
Free account.
Disclaimer